How the Gilead-Kite Pharma Deal Is Driving Biotech Stocks
After two months of churn, biotech stocks are suddenly red-hot thanks to a blockbuster Gilead-Kite Pharma deal that's propping up the entire sector.
Read More
After two months of churn, biotech stocks are suddenly red-hot thanks to a blockbuster Gilead-Kite Pharma deal that's propping up the entire sector.
Read More
Over time, small-caps have been the best place to invest your money as an investor in individual stocks.
Read More
Over time, small-caps have been the best place to invest your money—they're exceptional builders of wealth.
Read More
Over time, small-caps have been the best place to invest your money—they're exceptional builders of wealth.
Read More
Earlier this week, I took the subway to Downtown Brooklyn in 19-degree weather to report for Jury Duty. New York has a very busy court system, so I wound up being interviewed for a jury within a couple hours of arriving. A lawyer a..
Read More
Today I have the second part of my Q&A with small-cap expert Tom Garrity.
Read More